Medipost's Celltree Surpasses 340,000 Cumulative Cord Blood Storage Clients

Preparing for the Future of Regenerative Medicine

Medipost announced that Celltree, its umbilical cord blood bank brand, has surpassed 340,000 cumulative cord blood storage customers.

A representative from Celltrion is inspecting stored umbilical cord blood. Medipost

On August 28, Medipost stated that the achievement was driven by the steady demand to store umbilical cord blood—a resource that can be collected only once at birth—as a future medical asset for individuals and families.

Umbilical cord blood contains not only hematopoietic stem cells but also stem cells and immune cells. It is currently used to treat blood disorders such as leukemia and lymphoma, and more recently, clinical and research applications have expanded to include conditions like cerebral palsy and autism.

Celltree emphasized that it is strengthening its leading position in the domestic market based on accumulated storage and transplantation data as well as its cord blood management capabilities. The company also highlighted that interest in cord tissue storage is rising alongside recent regulatory improvements and increased research on the use of stem cells. In March, Celltree became the first in Korea to launch a "cord tissue-derived stem cell storage service."

While umbilical cord blood has demonstrated its therapeutic potential as a life resource through more than 45,000 transplants worldwide, cord tissue is rich in mesenchymal stem cells (MSCs), making it a key resource for the future of regenerative medicine. According to the company, storing both cord blood and tissue allows for the preservation of distinct stem cell types, thus preparing for advancements in regenerative medical technologies.

Internationally, services for storing both cord blood and cord tissue are already expanding. According to Parent's Guide to Cord Blood Foundation, a U.S.-based nonprofit, the growth of research and clinical use for both resources has led major overseas cord blood banks to offer services that store both cord blood and cord tissue together.

A Medipost representative said, "Surpassing 340,000 cumulative storage cases is the result of our customers’ accumulated trust in the value of cord blood and their preparations for the future," and added, "We will continue to promote the value of storing both cord blood and cord tissue and expand related services in line with the rapidly advancing era of regenerative medicine."

This content was produced with the assistance of AI translation services.